The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis
However, each exposure shortens the remaining shelf life
In the broader GLP-1 market, GLP-1+GIP dual-agonist formulations are commonly associated with tirzepatide, the active ingredient in brand-name Zepbound
It is important to note, however, that Retatrutide is still in Phase 3 clinical trials (the TRIUMPH programme), and its full regulatory approval is expected in 20262027
Adequate hydration and dietary fiber intake help manage this side effect
Regular reviews help optimise dosing, manage side effects, and ensure treatment remains safe and effective for each patients profile